The Clinical Impact of the Omicron Variant on Octogenarian Hospitalized COVID-19 Patients: The Results from CoviCamp Cohort
Pierantonio Grimaldi(University of Campania "Luigi Vanvitelli"), Fabio Giuliano Numis(Ospedale Santa Maria), Grazia Russo(Ospedale Santa Maria), Rossella Pacilio(Ospedale D. Cotugno), Elio Manzillo(Ospedale Monaldi), Giovanni Di Caprio(Ospedale Sant'Anna), Sebastiano Leone(Institute of Food Science), Mariantonietta Pisaturo(University of Antwerp), Vincenzo Sangiovanni(Ospedale Sant'Anna), Antonio Russo, Canio Carriero(University of Brescia), Roberto Parrella(Ospedale D. Cotugno), Michele Gambardella, Ivan Gentile(University of Naples Federico II), Salvatore Martini(University of Campania "Luigi Vanvitelli"), Antonio Ponticiello(Ospedale Sant'Anna), Alfonso Masullo(Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona), Raffaella Pisapia(University of Naples Federico II), Vincenzo Esposito(International Society for Computational Biology), Francesca Ambrisi(University of Campania "Luigi Vanvitelli"), Giosuele Calabria(Ospedale D. Cotugno), Filomena Milite(University of Campania "Luigi Vanvitelli")
Cited by 0
Related Papers
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
|Journal of Translational Medicine|2020|113
Anticoagulant treatment in COVID-19: a narrative review
|Journal of Thrombosis and Thrombolysis|2020|111